Approval · Notice of Compliance 7645 · 2005

PRAVASA: Notice of Compliance 7645

Issued December 7, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 7645
Date: December 7, 2005
Company: Paladin Labs Inc
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other
Therapeutic class: Platelet aggregation inhibitor & lipid metabolism regulator

Products in this notice

Brand	DIN	Status today
PRAVASA	02272415	Cancelled Post Market
PRAVASA	02272423	Cancelled Post Market
PRAVASA	02272431	Cancelled Post Market
PRAVASA	02272458	—
PRAVASA	02272466	—
PRAVASA	02272474	—

Medicinal ingredients

ACETYLSALICYLIC ACID 81 MG per TAB
PRAVASTATIN SODIUM 20 MG per TAB
PRAVASTATIN SODIUM 40 MG per TAB
ACETYLSALICYLIC ACID 162 MG per TAB
PRAVASTATIN SODIUM 10 MG per TAB